A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment

BACKGROUND: Nausea/vomiting (N/V) not related to anti-cancer treatment is common in patients with advanced cancer. The standard approach to management is to define a dominant cause, and treat with an antiemetic selected through pathophysiologic knowledge of emetic pathways. High rates of N/V control...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Hardy, Janet, Skerman, Helen, Glare, Paul, Philip, Jennifer, Hudson, Peter, Mitchell, Geoffrey, Martin, Peter, Spruyt, Odette, Currow, David, Yates, Patsy
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5932901/
https://ncbi.nlm.nih.gov/pubmed/29720113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4404-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados